ALPS Medical Breakthroughs ETF (SBIO) |
| 54.09 -0.12 (-0.22%) 05-29 15:59 |
| Open: | 54.285 |
| High: | 54.67 |
| Low: | 53.92 |
| Volume: | 63,384 |
| Market Cap: | 161(M) |
| PE Ratio: | 0 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 66.62 |
| Resistance 1: | 57.04 |
| Pivot price: | 53.88 |
| Support 1: | 53.00 |
| Support 2: | 50.51 |
| 52w High: | 57.77 |
| 52w Low: | 28.6 |
The ALPS Medical Breakthroughs ETF (SBIO) seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network Medical Breakthroughs Index (PMBI).
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Tue, 26 May 2026
Responsive Playbooks and the SBIO Inflection - Stock Traders Daily
Fri, 15 May 2026
Understanding the Setup: (SBIO) and Scalable Risk - Stock Traders Daily
Mon, 04 May 2026
The Technical Signals Behind (SBIO) That Institutions Follow - Stock Traders Daily
Thu, 23 Apr 2026
Precision Trading with Alps Medical Breakthroughs Etf (SBIO) Risk Zones - Stock Traders Daily
Thu, 09 Apr 2026
A Few Reasons Why Small-Cap ETFs Are Good Bets Now - TradingView
Wed, 08 Apr 2026
Biotech M&A Spree Helps Lead SBIO to March Gains - ETF Trends
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
